Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Medicine

Topics

Medicine

Cancer Oncology

Immunology

Internal Medicine

Gastroenterology

Show all topics

DOI

10.1038/nm.4307

Other Formats

PDF